News related to Isentress (Raltegravir) and/or conditions it is approved for
Combination Antiviral Recommended in EU for HIV Treatment
Source: Medscape Medical News Headlines [2015.01.23]
A lamivudine/raltegravir combination is expected to ease the daily pill burden for patients with HIV, with efficacy comparable to that of the individual agents.
Research suggests possible HIV risk with birth control shot
Source: Fertility News From Medical News Today [2015.01.23]
Analysis of several studies measuring rates of HIV infection among women using hormonal contraceptives in sub-Saharan Africa has suggested that birth shots could increase HIV risk.
Monkey model suggests cabotegravir could reduce dosing for high risk HIV patients
Source: HIV / AIDS News From Medical News Today [2015.01.20]
A regime of anti-HIV drugs -- components of regimens to treat established HIV infection -- has the potential to protect against infection in the first place.